Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-049237

Director sold 185,000 shares at an average $29.41 ($5,440,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PERRY MICHAEL S Director 2019-09-09 Sale −100,000 $28.90 $2,890,000 121,000 D
PERRY MICHAEL S Director 2019-09-11 Sale −85,000 $30.00 $2,550,000 36,000 D
Open-market sales · 185,000 sh · avg $29.41 · $5,440,000
Loading xslF345X03/doc4.xml…